Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines.

To demonstrate the differences of clinical features and hematologic abnormalities between dengue fever (DF) and dengue hemorrhagic fever (DHF), 359 pediatric patients admitted St. Luke's Medical Center in Quezon City, between 1999 and 2001 in Metro Manila, and adjoining provinces the Philippines, with a laboratory-confirmed dengue virus infection were evaluated. One third of the patients had DHF, and most of these patients were without shock. Restlessness, epistaxis, and abdominal pain were more associated with DHF. The platelet count was significantly lower in the DHF group than in the DF group before and after defervescence. In the DHF patients, the hematocrit was significantly increased before defervescence, and decreased the day after due to administration of intravenous fluid. Coagulation abnormalities associated with most DHF patients were thrombocytopenia and an increased fibrinolysis, but not disseminated intravascular coagulation. We present recent data on readily obtained clinical and laboratory data that can be used for early diagnosis and consequently earlier appropriate treatment of dengue virus infections.

[1]  C. Hayes,et al.  Dengue fever/dengue haemorrhagic fever in Filipino children: clinical experience during the 1983-1984 epidemic. , 1987, The Southeast Asian journal of tropical medicine and public health.

[2]  M. Saeed,et al.  Dengue and Dengue Hemorrhagic Fever , 2015 .

[3]  S. Kabra,et al.  Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  A. Igarashi Impact of dengue virus infection and its control. , 1997, FEMS immunology and medical microbiology.

[5]  G. Crane Dengue haemorrhagic fever: diagnosis, treatment, prevention and control , 1999 .

[6]  G. Pugliese,et al.  Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.

[7]  S. Nimmannitya,et al.  Clinical spectrum and management of dengue haemorrhagic fever. , 1987, The Southeast Asian journal of tropical medicine and public health.

[8]  S. Nimmannitya,et al.  Atypical lymphocyte in dengue hemorrhagic fever: its value in diagnosis. , 1984, The Southeast Asian journal of tropical medicine and public health.

[9]  A. Nisalak,et al.  Mechanisms of hemorrhage in dengue without circulatory collapse. , 2001, The American journal of tropical medicine and hygiene.

[10]  Lester R Curtin,et al.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. , 2002, Pediatrics.

[11]  C. Hayes,et al.  Dengue infections in the Philippines: clinical and virological findings in 517 hospitalized patients. , 1988, The American journal of tropical medicine and hygiene.

[12]  Melani W. Setiawan,et al.  Epigastric pain and sonographic assessment of the pancreas in dengue hemorrhagic fever , 1998, Journal of clinical ultrasound : JCU.

[13]  N. Marchette,et al.  The Greater Manila dengue hemorrhagic fever epidemic of 1966. , 1972 .

[14]  K. Morita,et al.  Rapid identification of dengue virus serotypes by using polymerase chain reaction , 1991, Journal of clinical microbiology.

[15]  A. Nisalak,et al.  Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens. , 2002, Journal of virological methods.

[16]  A. Igarashi,et al.  Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients. , 1985, Journal of virological methods.

[17]  A. Nisalak,et al.  Early clinical and laboratory indicators of acute dengue illness. , 1997, The Journal of infectious diseases.

[18]  W. Hammon,et al.  Viruses Associated with Epidemic Hemorrhagic Fevers of the Philippines and Thailand , 1960, Science.

[19]  E. Harris,et al.  Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. , 1999, The American journal of tropical medicine and hygiene.

[20]  S. Boonpucknavig,et al.  The pattern and nature of the lymphocyte population response in dengue hemorrhagic fever. , 1979, The American journal of tropical medicine and hygiene.

[21]  Yee‐Shin Lin,et al.  Activation of coagulation and fibrinolysis during dengue virus infection , 2001, Journal of Medical Virology.

[22]  Jiin‐Yu Wang,et al.  Clinical and upper gastroendoscopic features of patients with dengue virus infection , 1990, Journal of gastroenterology and hepatology.

[23]  N. M. Dung,et al.  Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[25]  M. Guzmán,et al.  Dengue: an update. , 2002, The Lancet. Infectious diseases.

[26]  T. Matsukawa,et al.  Is protease inhibitor a choice for the treatment of pre‐ or mild disseminated intravascular coagulation? , 2000, Critical care medicine.

[27]  T. Srichaikul,et al.  Fibrinogen Metabolism and Disseminated Intravascular Coagulation in Dengue Hemarrhagic Fever , 1977, Thrombosis and Haemostasis.

[28]  N. Sangkawibha,et al.  Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. , 1977, The American journal of tropical medicine and hygiene.

[29]  W. Gropp,et al.  Accepted for publication , 2001 .

[30]  A. Nisalak,et al.  Dengue in the early febrile phase: viremia and antibody responses. , 1997, The Journal of infectious diseases.